GSK continues with tender offer to acquire all outstanding shares of Human Genome Sciences

GSK continues with tender offer to acquire all outstanding shares of Human Genome Sciences

By: 1888PressRelease - Full Feed

Posted on June 16, 2012 at 07:22 AM EDT

GlaxoSmithKline plc (LSE: GSK) today confirmed that it has received a renewed invitation from Human Genome SciencesÂ’ (NASDAQ: HGSI) to participate in its strategic alternatives review process which started in April.

Related Stocks:

GlaxoSmithKline PLC ADS

Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates